Edoxaban was at least as effective as warfarin in preventing thromboembolism after bioprosthetic valve replacement in the ...

In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...

Japanese researchers say they have found a pill that works as well as existing medication to prevent blood clots afte ...

Dr Eric Berg DC, who is known as The Knowledge Doc, has shared the 'amazing benefits' of taking half a teaspoon of a ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Boston Scientific (BSX) stock climbed 5% after a study showed its Watchman FLX device was superior to oral anti-coagulants in reducing bleeding risks following cardiac ablation.

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Boston Scientific announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX device.

DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

Key findings from the study comparing the device to first-line oral anticoagulation (OAC) – including direct oral ...

Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...

Low event rates and short TTRs with warfarin were notable, and questions persist as to which patients truly need OAC.